Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that harnesses ...
Benzinga.com4d
Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside
Needham initiates Absci coverage with a Buy rating and a $9 price target, citing robust proprietary technology. Absci’s partnerships with Merck, AstraZeneca, and Almirall provide milestone ...
Absci shares jump as analyst lauds 'practical' AI drug company
"In our view, the ability to generate high quality wet-lab data is critical for advancement," analyst says in initiating ...
Investing4d
Needham initiates Absci shares with Buy rating on strategy
Absci's recent strategic collaborations with Advanced Micro Devices (NASDAQ:AMD) and AstraZeneca (NASDAQ:AZN) were also spotlighted. The partnership with AMD, which includes a $20 million ...
Investing4d
Needham initiates Absci shares with Buy rating on strategy
Absci's recent strategic collaborations with Advanced Micro Devices (NASDAQ:AMD) and AstraZeneca (NASDAQ:AZN) were also spotlighted. The partnership with AMD, which includes a $20 million investment, ...